Non-Hodgkin lymphoma, a cancer that is diagnosed in the U.S. more than 70,000 times annually, arises from overly proliferating immune cells within the body's lymph nodes, which are connected to a network of lymph vessels ...
Apr 12, 2018
0
38
A unique approach to targeting the abnormal T-cells that cause T-cell lymphomas could offer hope to patients with the aggressive and difficult-to-treat family of cancers, finds a study involving researchers from Cardiff University.
Nov 14, 2017
0
147
Follicular lymphoma is an incurable cancer that affects over 200,000 people worldwide every year. A form of non-Hodgkin lymphoma, follicular lymphoma develops when the body starts making abnormal B-cells, which are white ...
Jun 28, 2017
0
31
A compound identified by Weill Cornell Medicine scientists inhibits the growth of a rare blood cancer found in people with HIV-AIDS. Their research, published May 15 in the Journal of Clinical Investigation, also demonstrates ...
May 17, 2017
0
221
Sequencing tiny bits of DNA circulating in the blood of patients with lymphoma can accurately identify the cancer subtype and pinpoint mutations that might cause drug resistance, according to researchers at the Stanford University ...
Nov 9, 2016
0
87
When University of Colorado Cancer Center researcher, Jing Hong Wang, MD, PhD, found more than 1,000 genetic translocations in her mouse model of B cell lymphoma, she assumed her lab had made a mistake. To rule out experimental ...
Oct 27, 2016
0
42
Patients with non-Hodgkin lymphoma participating in an early-phase immunotherapy trial led by Fred Hutchinson Cancer Research Center had their advanced tumors disappear completely after their immune cells were genetically ...
Sep 7, 2016
0
168
In a step toward more targeted treatments for cancer patients, UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center researchers have demonstrated how a genetic mutation drives the most common type of lymphoma ...
May 4, 2016
0
54
At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research at Washington University School of Medicine in St. Louis.
Oct 19, 2014
0
0
A protein molecule, "BINDI," has been built to trigger self-destruction of cancer cells infected with the Epstein-Barr virus.
Jun 19, 2014
0
0
